BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 19133800)

  • 1. Single-dose nevirapine to prevent mother-to-child transmission of HIV type 1: balancing the benefits and risks.
    Mellors JW; Chow JY
    Clin Infect Dis; 2009 Feb; 48(4):473-5. PubMed ID: 19133800
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV-1 drug resistance and mother-to-child transmission.
    Morris L; Pillay C; Gray G; McIntyre J
    SADJ; 2001 Dec; 56(12):614-6. PubMed ID: 11887450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. This is no time to stop use of nevarapine to prevent mother-to-child transmission of HIV.
    Oleske JM
    AIDS; 2006 Apr; 20(7):1059-60. PubMed ID: 16603859
    [No Abstract]   [Full Text] [Related]  

  • 4. Nevirapine plus zidovudine to prevent mother-to-child transmission of HIV.
    Herzmann C; Karcher H
    N Engl J Med; 2004 Nov; 351(19):2013-5; author reply 2013-5. PubMed ID: 15525729
    [No Abstract]   [Full Text] [Related]  

  • 5. The controversies of nevirapine for preventing mother-to-child HIV transmission.
    Smith DM
    AIDS; 2006 Jan; 20(2):281-3. PubMed ID: 16511423
    [No Abstract]   [Full Text] [Related]  

  • 6. Preventing mother-to-child transmission of HIV: successes and challenges.
    McIntyre J
    BJOG; 2005 Sep; 112(9):1196-203. PubMed ID: 16101596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV: mother to child transmission.
    Volmink J
    Clin Evid; 2003 Jun; (9):785-94. PubMed ID: 12967392
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of HIV drug resistance mutations in pregnant women receiving single dose Nevirapine in south India.
    Jacob MS; Durairaj A; Vijayakumari J; Srijayanth P; Sivakumar MR
    Indian J Pathol Microbiol; 2011; 54(2):359-61. PubMed ID: 21623090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of pediatric AIDS clinical trials group protocol 316.
    Cunningham CK; Chaix ML; Rekacewicz C; Britto P; Rouzioux C; Gelber RD; Dorenbaum A; Delfraissy JF; Bazin B; Mofenson L; Sullivan JL
    J Infect Dis; 2002 Jul; 186(2):181-8. PubMed ID: 12134253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of drug-resistant HIV-1 in latent reservoirs.
    Dahl V; Palmer S
    J Infect Dis; 2009 May; 199(9):1258-60. PubMed ID: 19338473
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV: mother to child transmission.
    Volmink J; Mahlat U
    Clin Evid; 2005 Jun; (13):823-33. PubMed ID: 16135280
    [No Abstract]   [Full Text] [Related]  

  • 12. Nevirapine plus zidovudine to prevent mother-to-child transmission of HIV.
    Goulder PJ; Blanckenberg N; Dong K
    N Engl J Med; 2004 Nov; 351(19):2013-5; author reply 2013-5. PubMed ID: 15529448
    [No Abstract]   [Full Text] [Related]  

  • 13. Zidovudine with nevirapine for the prevention of HIV mother-to-child transmission reduces nevirapine resistance in mothers from the Western Cape, South Africa.
    van Zyl GU; Claassen M; Engelbrecht S; Laten JD; Cotton MF; Theron GB; Preiser W
    J Med Virol; 2008 Jun; 80(6):942-6. PubMed ID: 18428139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Encouraging study results. HIV from birth on--virostatic drugs can decrease the risk].
    MMW Fortschr Med; 1999 Aug; 141(34):61. PubMed ID: 10726137
    [No Abstract]   [Full Text] [Related]  

  • 15. Nevirapine may promote resistance.
    AIDS Patient Care STDS; 2004 Apr; 18(4):249-50. PubMed ID: 15154406
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence behind the WHO guidelines: hospital care for children: what antiretroviral agents and regimens are effective in the prevention of mother-to-child transmission of HIV?
    Nightingale S; Dabis F
    J Trop Pediatr; 2006 Aug; 52(4):235-8. PubMed ID: 16877674
    [No Abstract]   [Full Text] [Related]  

  • 17. Scaling the frontier--should traditional birth attendants also be used to provide nevirapine for PMTCT in Uganda?
    Kironde S; Lukwago J; Ssenyonga R
    Afr Health Sci; 2003 Aug; 3(2):102-3. PubMed ID: 12913802
    [No Abstract]   [Full Text] [Related]  

  • 18. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.
    Dao H; Mofenson LM; Ekpini R; Gilks CF; Barnhart M; Bolu O; Shaffer N
    Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S42-55. PubMed ID: 17825650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nevirapine reduced mother-to-child transmission better than AZT--at 70 times less the cost.
    AIDS Treat News; 2003 Sep; (394):7. PubMed ID: 14669729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should nevirapine be used to prevent mother-to-child transmission of HIV among women of unknown serostatus?
    Sint TT; Dabis F; Kamenga C; Shaffer N; de Zoysa IF
    Bull World Health Organ; 2005 Mar; 83(3):224-8. PubMed ID: 15798847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.